{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T15:45:24Z","timestamp":1791819924509,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,12]],"date-time":"2026-07-12T00:00:00Z","timestamp":1783814400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001547","name":"China Medical Board Inc","doi-asserted-by":"publisher","award":["GNL 23-514"],"award-info":[{"award-number":["GNL 23-514"]}],"id":[{"id":"10.13039\/100001547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ijid.2026.108979","type":"journal-article","created":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:29:19Z","timestamp":1784071759000},"page":"108979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A systematic review and meta-analysis of the economic burden of carbapenem-resistant Enterobacterales (CRE) infection"],"prefix":"10.1016","volume":"171","author":[{"given":"Jiangnianyong","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiabin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lili","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6435-3276","authenticated-orcid":false,"given":"Shiyi","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2026.108979_sbref0001","series-title":"WHO bacterial priority pathogens list, 2024: bacterial pathogens of public health importance to guide research, development and strategies to prevent and control antimicrobial resistance","year":"2024"},{"key":"10.1016\/j.ijid.2026.108979_bib0002","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1128\/AAC.01882-17","article-title":"Epidemiology of carbapenem-resistant Enterobacteriaceae infections: report from the China CRE network","volume":"62","author":"Zhang","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2026.108979_bib0003","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2006.03.013","article-title":"Resistance in gram-negative bacteria: Enterobacteriaceae","volume":"119","author":"Paterson","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/j.ijid.2026.108979_bib0004","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1128\/AAC.00698-21","article-title":"Assessment of mortality-related risk factors and effective antimicrobial regimens for treatment of bloodstream infections caused by carbapenem-resistant Enterobacterales","volume":"65","author":"Chen","year":"2021","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2026.108979_bib0005","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2024.1528017","article-title":"Genome drafting of nosocomial infection CRE Klebsiella pneumoniae confirming resistance to colistin and eravacycline, carrying blaNDM-1, mcr-1, and blaKPC-2, in neonatology from November to December 2023","volume":"14","author":"Zhou","year":"2025","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijid.2026.108979_bib0006","doi-asserted-by":"crossref","DOI":"10.1016\/j.micres.2022.127249","article-title":"Global spread of carbapenem-resistant Enterobacteriaceae: epidemiological features, resistance mechanisms, detection and therapy","volume":"266","author":"Ma","year":"2023","journal-title":"Microbiol Res"},{"key":"10.1016\/j.ijid.2026.108979_bib0007","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drup.2016.09.002","article-title":"The rapid spread of carbapenem-resistant Enterobacteriaceae","volume":"29","author":"Potter","year":"2016","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ijid.2026.108979_bib0008","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2022.823684","article-title":"Global threat of carbapenem-resistant gram-negative bacteria","volume":"12","author":"Jean","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijid.2026.108979_bib0009","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jhin.2025.03.019","article-title":"Burden of carbapenem-resistant gram-negative bacterial infections in Vietnam: a national hospital survey","volume":"165","author":"Larsson","year":"2025","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijid.2026.108979_bib0010","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.ajic.2025.07.007","article-title":"Evaluation of the economic burden of carbapenem-resistant Enterobacteriaceae nosocomial infection in intensive care unit patients: a propensity score\u2014adjusted analysis","volume":"53","author":"Long","year":"2025","journal-title":"Am J Infect Control"},{"key":"10.1016\/j.ijid.2026.108979_sbref0011","series-title":"Global antimicrobial resistance and use surveillance system (GLASS) report 2022","year":"2022"},{"key":"10.1016\/j.ijid.2026.108979_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2016.09.003","article-title":"Potential economic burden of carbapenem-resistant Enterobacteriaceae (CRE) in the United States","volume":"23","author":"Bartsch","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2026.108979_bib0013","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2023.12.013","article-title":"Excess resource use and cost of drug-resistant infections for six key pathogens in Europe: a systematic review and Bayesian meta-analysis","volume":"30","author":"Kingston","year":"2024","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2026.108979_bib0014","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40258-025-01001-7","article-title":"The economics of antibiotic resistance: a systematic review and meta-analysis based on global research","volume":"24","author":"Siaba","year":"2025","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.ijid.2026.108979_bib0015","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ijid.2026.108979_bib0016","unstructured":"Wells G, Shea B, O\u2019Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp; 2013 [accessed 5 March 2026]."},{"issue":"2","key":"10.1016\/j.ijid.2026.108979_bib0017","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1017\/S0266462305050324","article-title":"Criteria list for assessment of methodological quality of economic evaluations: consensus on health economic criteria","volume":"21","author":"Evers","year":"2005","journal-title":"Int J Technol Assess Health Care"},{"key":"10.1016\/j.ijid.2026.108979_bib0018","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.20736","article-title":"Congenital cytomegalovirus infection burden and epidemiologic risk factors in countries with universal screening","volume":"4","author":"Ssentongo","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ijid.2026.108979_bib0019","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1212890","article-title":"Evaluation of Chlamydia trachomatis screening from the perspective of health economics: a systematic review","volume":"11","author":"Yao","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/j.ijid.2026.108979_bib0020","series-title":"Focus on health care prices","year":"2020"},{"key":"10.1016\/j.ijid.2026.108979_bib0021","first-page":"1","article-title":"Understanding differences in health care spending: a comparative study of prices and volumes across OECD countries","volume":"15","author":"Lorenzoni","year":"2022","journal-title":"Health Serv Insights"},{"key":"10.1016\/j.ijid.2026.108979_bib0022","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1111\/1475-6773.13708","article-title":"International comparison of health spending and utilization among people with complex multimorbidity","volume":"56","author":"Figueroa","year":"2021","journal-title":"Health Serv Res"},{"key":"10.1016\/j.ijid.2026.108979_bib0023","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/s13756-019-0590-7","article-title":"Economic burden of antibiotic resistance in ESKAPE organisms: a systematic review","volume":"8","author":"Zhen","year":"2019","journal-title":"Antimicrob Resist Infect Control"},{"key":"10.1016\/j.ijid.2026.108979_bib0024","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.2147\/IDR.S555843","article-title":"Economic burden of carbapenem-resistant organisms in critically ill patients: a multicenter, retrospective cohort study","volume":"18","author":"Jiang","year":"2025","journal-title":"Infect Drug Resist"},{"key":"10.1016\/j.ijid.2026.108979_bib0025","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02349-16","article-title":"Multicenter clinical and molecular epidemiological analysis of bacteremia due to carbapenem-resistant Enterobacteriaceae (CRE) in the CRE epicenter of the United States","volume":"61","author":"Satlin","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2026.108979_bib0026","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jhin.2025.07.030","article-title":"Prevalence of carbapenem-resistant Enterobacterales in healthcare and community settings in the UK: a systematic review and meta-analysis","volume":"165","author":"Almadhoon","year":"2025","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijid.2026.108979_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2025.1734801","article-title":"Risk factors, and outcomes of patients with carbapenem-resistant Enterobacterales bloodstream infection: an eight-year case-case-control study","volume":"15","author":"Kong","year":"2026","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.ijid.2026.108979_bib0028","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s40258-025-01001-7","article-title":"The economics of antibiotic resistance: a systematic review and meta-analysis based on global research","volume":"24","author":"Siaba","year":"2025","journal-title":"Appl Health Econ Health Policy"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226006144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971226006144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:47:19Z","timestamp":1791816439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971226006144"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":28,"alternative-id":["S1201971226006144"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108979","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A systematic review and meta-analysis of the economic burden of carbapenem-resistant Enterobacterales (CRE) infection","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2026.108979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.","name":"copyright","label":"Copyright"}],"article-number":"108979"}}